Multiple session mesotherapy for management of coxofemoral osteoarthritis pain in 10 working dogs: A case series
Autor:
Alves, João C.
; Santos, Ana
; Jorge, Patrícia
; Lafuente, Pilar
Fecha:
2022Palabra clave:
Revista / editorial:
Canadian Veterinary JournalCitación:
Alves JC, Santos A, Jorge P, Lafuente P. Multiple session mesotherapy for management of coxofemoral osteoarthritis pain in 10 working dogs: A case series. Can Vet J. 2022 Jun;63(6):597-602. PMID: 35656532; PMCID: PMC9112366.Tipo de Ítem:
Articulo Revista IndexadaDirección web:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112366/Resumen:
The aim of this study was to document the effects of mesotherapy in working dogs diagnosed with hip osteoarthritis (OA) and related pain. Ten police working dogs with hip OA and related pain were treated with a combination of lidocaine, piroxicam, and thiocolchicoside, injected in multiple intradermal points. Seven treatment sessions were conducted. The Canine Brief Pain Inventory (CBPI) and the Hudson Visual Analogue Scale (HVAS) were used in the assessment of response to treatment compared to evaluation before treatment (TO), after 15 d, 30 d, 60 d, 90 d, 120 d, 150 d, and 180 d after initial treatment. Results were compared using the Wilcoxon signed-rank test. Significant differences were experienced in CBPI scores comparing moments with TO: at 15 d (P = 0.03 for Pain Interference Score - PIS) and P = 0.02 for Pain Severity Score - PSS), 30 d (P < 0.05 for PIS and P < 0.05 for PSS), 60 d (P = 0.04 for PIS and P = 0.01 for PSS) and 180 d (P = 0.04 for PSS). Individual treatment results were considered successful in 40% of animals at 15 d and 30 d, 66.7% at 60 d, 44% at 90 d, 37.5% at 120 d, and 25% at 150 d. The HVAS scores showed no significant differences. Mesotherapy may be an option for the treatment of canine musculoskeletal-related pain. Further studies are required.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
42 |
64 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
A multiple-session mesotherapy protocol for the management of hip osteoarthritis in police working dogs
Alves, João C.; Santos, Ana; Jorge, Patrícia; Lafuente, Pilar (American Journal of Veterinary Research, 2023)OBJECTIVE To describe the effect of a mesotherapy protocol in dogs with osteoarthritis. ANIMALS 30 dogs. PROCEDURES Dogs were randomly assigned to a control (CG; n = 10) or a mesotherapy group (MG; 20). CG received meloxicam ... -
Main differences between the first and second waves of COVID-19 in Madrid, Spain
Soriano, Vicente ; Ganado-Pinilla, Pilar ; Sánchez-Santos, Miguel ; Gómez-Gallego, Felix ; Barreiro, Pablo; de Mendoza, Carmen; Corral, Octavio Jorge (International journal of infectious diseases, 2021)Background: The emergence and rapid global spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) represents a major challenge to health services, and has disrupted social and economic activities worldwide. ... -
COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study
Moreno-Torres, Víctor; Martínez-Urbistondo, María; Calderón-Parra, Jorge; Mills, Patricia; Muñoz Serrano, Alejandro; Arias-Milla, Ana; Benítez, Laura; Aguilar-Pérez, Myriam; Múñez-Rubio, Elena; Ramos-Martínez, Antonio; Fernández-Cruz, Ana; Cuervas-Mons, Valentín; de Mendoza, Carmen (International Journal of Infectious Diseases, 2023)Objectives: Underlying immunodeficiency has been associated with worse clinical presentation and increased mortality in patients with COVID-19. We evaluated the mortality of solid organ transplant (SOT) recipients (SOTR) ...